首页> 美国卫生研究院文献>British Medical Journal >Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study
【2h】

Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study

机译:制定加拿大临床实践指南的专家小组成员中存在财务利益冲突的普遍性:横断面研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective To determine the prevalence of financial conflicts of interest among members of panels producing clinical practice guidelines on screening, treatment, or both for hyperlipidaemia or diabetes.>Design Cross sectional study.>Setting Relevant guidelines published by national organisations in the United States and Canada between 2000 and 2010.>Participants Members of guideline panels.>Main outcome measures Prevalence of financial conflicts of interest among members of guideline panels and chairs of panels.>Results Fourteen guidelines met our search criteria, of which five had no accompanying declaration of conflicts of interest by panel members. 288 panel members had participated in the guideline development process. Among the 288 panel members, 138 (48%) reported conflicts of interest at the time of the publication of the guideline and 150 (52%) either stated that they had no such conflicts or did not have an opportunity to declare any. Among 73 panellists who formally declared no conflicts, 8 (11%) were found to have one or more. Twelve of the 14 guideline panels evaluated identified chairs, among whom six had financial conflicts of interest. Overall, 150 (52%) panel members had conflicts, of which 138 were declared and 12 were undeclared. Panel members from government sponsored guidelines were less likely to have conflicts of interest compared with guidelines sponsored by non-government sources (15/92 (16%) v 135/196 (69%); P<0.001).>Conclusions The prevalence of financial conflicts of interest and their under-reporting by members of panels producing clinical practice guidelines on hyperlipidaemia or diabetes was high, and a relatively high proportion of guidelines did not have public disclosure of conflicts of interest. Organisations that produce guidelines should minimise conflicts of interest among panel members to ensure the credibility and evidence based nature of the guidelines' content.
机译:>目的:确定在制定针对高脂血症或糖尿病的筛查和/或治疗的临床实践指南的小组成员中,存在财务利益冲突的患病率。>设计横断面研究。 strong> Settings (设置)由美国和加拿大的国家组织在2000年至2010年之间发布的相关指南。>参与者指南小组的成员。>主要成果指标 >结果有14条符合我们的搜索标准的准则,其中5条没有随附小组成员的利益冲突声明。 288名小组成员参加了指南制定过​​程。在288名专家组成员中,有138名(48%)报告在本指南发布时存在利益冲突,还有150名(52%)表示他们没有此类冲突或没有机会宣布任何冲突。在正式宣布没有冲突的73名小组成员中,有8名(11%)被发现有一个或多个。 14个指导小组中有12个对确定的主席进行了评估,其中6个存在财务利益冲突。总体而言,有150名(52%)小组成员发生了冲突,其中宣布了138次,未宣布12次。与非政府组织赞助的指南相比,政府赞助的指南的小组成员不太可能发生利益冲突(15/92(16%)对135/196(69%); P <0.001)。>结论< / strong>财务利益冲突的患病率很高,而制定高脂血症或糖尿病临床实践指南的专家小组成员的报告不足,并且有较高比例的指南没有公开披露利益冲突。制定准则的组织应最大程度地减少小组成员之间的利益冲突,以确保准则内容的可信性和基于证据的性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号